Skip to main content
NRIX
NASDAQ Life Sciences

Nurix-Roche $2.3B BTK Degrader Deal Clears Antitrust Hurdle

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$23.69
Mkt Cap
$2.437B
52W Low
$8.195
52W High
$25.085
52W Position info
189% above low
Off High info
5.6% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

NRIX has more than doubled off its 52-week low of $8.195.

Summary

The Hart-Scott-Rodino waiting period expired, clearing the last major regulatory hurdle for the Nurix-Roche collaboration announced June 8. The deal includes a $700M upfront payment, up to $2.3B in milestones, and a 40/60 cost split. With antitrust clearance, the partnership can now close, bringing Nurix's pro-forma cash to ~$1.14B and derisking the bexobrutideg program. The collaboration spans CLL, B-cell malignancies, MS, and CSU, with Roche leading ex-U.S. commercialization. This follows the June 11 positive Phase 1b data and Q2 earnings showing a $443.5M cash position. The clearance removes uncertainty and allows the companies to advance the Phase 2 trial.

At the time of this announcement, NRIX was trading at $23.69 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $8.20 to $25.09. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

NRIX - Latest Insights

NRIX
Nov 03, 2026, 4:02 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.03
Real-time Price: $14.24 info
Change: -$7.79 (-35%) info
Market Cap: $1.556B info
NRIX
Nov 03, 2026, 4:01 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $17.88
Real-time Price: $14.24 info
Change: -$3.64 (-20%) info
Market Cap: $1.556B info
NRIX
Oct 13, 2026, 6:21 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $22.50
Real-time Price: $14.24 info
Change: -$8.26 (-37%) info
Market Cap: $1.556B info
NRIX
Oct 13, 2026, 6:19 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.50
Real-time Price: $14.24 info
Change: -$8.26 (-37%) info
Market Cap: $1.556B info
NRIX
Oct 12, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $23.06
Real-time Price: $14.24 info
Change: -$8.82 (-38%) info
Market Cap: $1.556B info